http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Tue, 19 May 2026 08:30:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Press+Releases/Evolus+to+Participate+in+The+Jefferies+Global+Healthcare+Conference/26517863.html <p> NEWPORT BEACH, Calif.--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.evolus.com%2Four-culture%2F&amp;esheet=54535609&amp;newsitemid=20260519075871&amp;lan=en-US&amp;anchor=Evolus%2C+Inc.&amp;index=1&amp;md5=ca6b603af1c0892e94416d10c72dd22d" shape="rect">Evolus, Inc.</a> (NASDAQ: EOLS), a performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today announced members of its management team will participate in a fireside chat and investor meetings at the upcoming Jefferies Global Healthcare Conference in New York City. </p><p> The fireside chat will take place on Thursday, June 4th, 2026, at 12:50 PM ET. </p><p> The fireside chat can be accessed on the Investor Relations page of the Evolus website <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Finvestors.evolus.com%2Fevents-and-presentations%2Fdefault.aspx&amp;esheet=54535609&amp;newsitemid=20260519075871&amp;lan=en-US&amp;anchor=here&amp;index=2&amp;md5=ee480abaca60e317a2f87928c5080f44" shape="rect">here</a>. A replay of the webcast will be available 90 days http://www.streetinsider.com/Press+Releases/Evolus+to+Participate+in+The+Jefferies+Global+Healthcare+Conference/26517863.html Tue, 19 May 2026 08:30:00 -0400 EOLS O.37510556 http://www.streetinsider.com/Press+Releases/Evolus+to+Participate+in+The+Jefferies+Global+Healthcare+Conference/26517863.html <p> NEWPORT BEACH, Calif.--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.evolus.com%2Four-culture%2F&amp;esheet=54535609&amp;newsitemid=20260519075871&amp;lan=en-US&amp;anchor=Evolus%2C+Inc.&amp;index=1&amp;md5=ca6b603af1c0892e94416d10c72dd22d" shape="rect">Evolus, Inc.</a> (NASDAQ: EOLS), a performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today announced members of its management team will participate in a fireside chat and investor meetings at the upcoming Jefferies Global Healthcare Conference in New York City. </p><p> The fireside chat will take place on Thursday, June 4th, 2026, at 12:50 PM ET. </p><p> The fireside chat can be accessed on the Investor Relations page of the Evolus website <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Finvestors.evolus.com%2Fevents-and-presentations%2Fdefault.aspx&amp;esheet=54535609&amp;newsitemid=20260519075871&amp;lan=en-US&amp;anchor=here&amp;index=2&amp;md5=ee480abaca60e317a2f87928c5080f44" shape="rect">here</a>. A replay of the webcast will be available 90 days http://www.streetinsider.com/Press+Releases/Evolus+to+Participate+in+The+Jefferies+Global+Healthcare+Conference/26517863.html Tue, 19 May 2026 08:30:00 -0400 EOLS O.37510556 http://www.streetinsider.com/Business+Wire/Evolus+to+Participate+in+The+Jefferies+Global+Healthcare+Conference/26517863.html <p> NEWPORT BEACH, Calif.--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.evolus.com%2Four-culture%2F&amp;esheet=54535609&amp;newsitemid=20260519075871&amp;lan=en-US&amp;anchor=Evolus%2C+Inc.&amp;index=1&amp;md5=ca6b603af1c0892e94416d10c72dd22d" shape="rect">Evolus, Inc.</a> (NASDAQ: EOLS), a performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today announced members of its management team will participate in a fireside chat and investor meetings at the upcoming Jefferies Global Healthcare Conference in New York City. </p><p> The fireside chat will take place on Thursday, June 4th, 2026, at 12:50 PM ET. </p><p> The fireside chat can be accessed on the Investor Relations page of the Evolus website <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Finvestors.evolus.com%2Fevents-and-presentations%2Fdefault.aspx&amp;esheet=54535609&amp;newsitemid=20260519075871&amp;lan=en-US&amp;anchor=here&amp;index=2&amp;md5=ee480abaca60e317a2f87928c5080f44" shape="rect">here</a>. A replay of the webcast will be available 90 days http://www.streetinsider.com/Business+Wire/Evolus+to+Participate+in+The+Jefferies+Global+Healthcare+Conference/26517863.html Tue, 19 May 2026 08:30:00 -0400 EOLS O.37510556 http://www.streetinsider.com/Business+Wire/Evolus+to+Participate+in+The+Jefferies+Global+Healthcare+Conference/26517863.html <p> NEWPORT BEACH, Calif.--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.evolus.com%2Four-culture%2F&amp;esheet=54535609&amp;newsitemid=20260519075871&amp;lan=en-US&amp;anchor=Evolus%2C+Inc.&amp;index=1&amp;md5=ca6b603af1c0892e94416d10c72dd22d" shape="rect">Evolus, Inc.</a> (NASDAQ: EOLS), a performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today announced members of its management team will participate in a fireside chat and investor meetings at the upcoming Jefferies Global Healthcare Conference in New York City. </p><p> The fireside chat will take place on Thursday, June 4th, 2026, at 12:50 PM ET. </p><p> The fireside chat can be accessed on the Investor Relations page of the Evolus website <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Finvestors.evolus.com%2Fevents-and-presentations%2Fdefault.aspx&amp;esheet=54535609&amp;newsitemid=20260519075871&amp;lan=en-US&amp;anchor=here&amp;index=2&amp;md5=ee480abaca60e317a2f87928c5080f44" shape="rect">here</a>. A replay of the webcast will be available 90 days http://www.streetinsider.com/Business+Wire/Evolus+to+Participate+in+The+Jefferies+Global+Healthcare+Conference/26517863.html Tue, 19 May 2026 08:30:00 -0400 EOLS O.37510556 http://www.streetinsider.com/Corporate+News/Evolus+launches+Estyme+hyaluronic+acid+gels+in+Europe/26465710.html <p>Evolus Inc. (NASDAQ: EOLS) announced the commercial launch of its Estyme injectable hyaluronic acid gel collection in Europe on May 16, marking the company's entry into the international dermal filler market.</p> <p>The Estyme collection includes four injectable hyaluronic acid gels: Estyme Smooth and Estyme Form, currently marketed in the United States under the Evolysse brand, along with two new products, Estyme Lips and Estyme Sculpt. Estyme Sculpt is designed for restoring mid-face volume and is expecting U.S. FDA approval later this year.</p> <p>The products are developed using Symatese's Cold-X technology, which the company states helps preserve the natural structure of the hyaluronic http://www.streetinsider.com/Corporate+News/Evolus+launches+Estyme+hyaluronic+acid+gels+in+Europe/26465710.html Mon, 11 May 2026 08:30:22 -0400 A.04927026 A.23887963 A.50214897 EOLS O.01223041 O.09434798 O.29688837 O.37510556 http://www.streetinsider.com/Corporate+News/Evolus+launches+Estyme+hyaluronic+acid+gels+in+Europe/26465710.html <p>Evolus Inc. (NASDAQ: EOLS) announced the commercial launch of its Estyme injectable hyaluronic acid gel collection in Europe on May 16, marking the company's entry into the international dermal filler market.</p> <p>The Estyme collection includes four injectable hyaluronic acid gels: Estyme Smooth and Estyme Form, currently marketed in the United States under the Evolysse brand, along with two new products, Estyme Lips and Estyme Sculpt. Estyme Sculpt is designed for restoring mid-face volume and is expecting U.S. FDA approval later this year.</p> <p>The products are developed using Symatese's Cold-X technology, which the company states helps preserve the natural structure of the hyaluronic http://www.streetinsider.com/Corporate+News/Evolus+launches+Estyme+hyaluronic+acid+gels+in+Europe/26465710.html Mon, 11 May 2026 08:30:22 -0400 A.04927026 A.23887963 A.50214897 EOLS O.01223041 O.09434798 O.29688837 O.37510556 http://www.streetinsider.com/Corporate+News/Evolus+launches+Estyme+hyaluronic+acid+gels+in+Europe/26465710.html <p>Evolus Inc. (NASDAQ: EOLS) announced the commercial launch of its Estyme injectable hyaluronic acid gel collection in Europe on May 16, marking the company's entry into the international dermal filler market.</p> <p>The Estyme collection includes four injectable hyaluronic acid gels: Estyme Smooth and Estyme Form, currently marketed in the United States under the Evolysse brand, along with two new products, Estyme Lips and Estyme Sculpt. Estyme Sculpt is designed for restoring mid-face volume and is expecting U.S. FDA approval later this year.</p> <p>The products are developed using Symatese's Cold-X technology, which the company states helps preserve the natural structure of the hyaluronic http://www.streetinsider.com/Corporate+News/Evolus+launches+Estyme+hyaluronic+acid+gels+in+Europe/26465710.html Mon, 11 May 2026 08:30:22 -0400 A.04927026 A.23887963 A.50214897 EOLS O.01223041 O.09434798 O.29688837 O.37510556 http://www.streetinsider.com/Corporate+News/Evolus+launches+Estyme+hyaluronic+acid+gels+in+Europe/26465710.html <p>Evolus Inc. (NASDAQ: EOLS) announced the commercial launch of its Estyme injectable hyaluronic acid gel collection in Europe on May 16, marking the company's entry into the international dermal filler market.</p> <p>The Estyme collection includes four injectable hyaluronic acid gels: Estyme Smooth and Estyme Form, currently marketed in the United States under the Evolysse brand, along with two new products, Estyme Lips and Estyme Sculpt. Estyme Sculpt is designed for restoring mid-face volume and is expecting U.S. FDA approval later this year.</p> <p>The products are developed using Symatese's Cold-X technology, which the company states helps preserve the natural structure of the hyaluronic http://www.streetinsider.com/Corporate+News/Evolus+launches+Estyme+hyaluronic+acid+gels+in+Europe/26465710.html Mon, 11 May 2026 08:30:22 -0400 A.04927026 A.23887963 A.50214897 EOLS O.01223041 O.09434798 O.29688837 O.37510556 http://www.streetinsider.com/Corporate+News/Evolus+launches+Estyme+hyaluronic+acid+gels+in+Europe/26465710.html <p>Evolus Inc. (NASDAQ: EOLS) announced the commercial launch of its Estyme injectable hyaluronic acid gel collection in Europe on May 16, marking the company's entry into the international dermal filler market.</p> <p>The Estyme collection includes four injectable hyaluronic acid gels: Estyme Smooth and Estyme Form, currently marketed in the United States under the Evolysse brand, along with two new products, Estyme Lips and Estyme Sculpt. Estyme Sculpt is designed for restoring mid-face volume and is expecting U.S. FDA approval later this year.</p> <p>The products are developed using Symatese's Cold-X technology, which the company states helps preserve the natural structure of the hyaluronic http://www.streetinsider.com/Corporate+News/Evolus+launches+Estyme+hyaluronic+acid+gels+in+Europe/26465710.html Mon, 11 May 2026 08:30:22 -0400 A.04927026 A.23887963 A.50214897 EOLS O.01223041 O.09434798 O.29688837 O.37510556 http://www.streetinsider.com/Corporate+News/Evolus+launches+Estyme+hyaluronic+acid+gels+in+Europe/26465710.html <p>Evolus Inc. (NASDAQ: EOLS) announced the commercial launch of its Estyme injectable hyaluronic acid gel collection in Europe on May 16, marking the company's entry into the international dermal filler market.</p> <p>The Estyme collection includes four injectable hyaluronic acid gels: Estyme Smooth and Estyme Form, currently marketed in the United States under the Evolysse brand, along with two new products, Estyme Lips and Estyme Sculpt. Estyme Sculpt is designed for restoring mid-face volume and is expecting U.S. FDA approval later this year.</p> <p>The products are developed using Symatese's Cold-X technology, which the company states helps preserve the natural structure of the hyaluronic http://www.streetinsider.com/Corporate+News/Evolus+launches+Estyme+hyaluronic+acid+gels+in+Europe/26465710.html Mon, 11 May 2026 08:30:22 -0400 A.04927026 A.23887963 A.50214897 EOLS O.01223041 O.09434798 O.29688837 O.37510556 http://www.streetinsider.com/Corporate+News/Evolus+launches+Estyme+hyaluronic+acid+gels+in+Europe/26465710.html <p>Evolus Inc. (NASDAQ: EOLS) announced the commercial launch of its Estyme injectable hyaluronic acid gel collection in Europe on May 16, marking the company's entry into the international dermal filler market.</p> <p>The Estyme collection includes four injectable hyaluronic acid gels: Estyme Smooth and Estyme Form, currently marketed in the United States under the Evolysse brand, along with two new products, Estyme Lips and Estyme Sculpt. Estyme Sculpt is designed for restoring mid-face volume and is expecting U.S. FDA approval later this year.</p> <p>The products are developed using Symatese's Cold-X technology, which the company states helps preserve the natural structure of the hyaluronic http://www.streetinsider.com/Corporate+News/Evolus+launches+Estyme+hyaluronic+acid+gels+in+Europe/26465710.html Mon, 11 May 2026 08:30:22 -0400 A.04927026 A.23887963 A.50214897 EOLS O.01223041 O.09434798 O.29688837 O.37510556 http://www.streetinsider.com/Corporate+News/Evolus+launches+Estyme+hyaluronic+acid+gels+in+Europe/26465710.html <p>Evolus Inc. (NASDAQ: EOLS) announced the commercial launch of its Estyme injectable hyaluronic acid gel collection in Europe on May 16, marking the company's entry into the international dermal filler market.</p> <p>The Estyme collection includes four injectable hyaluronic acid gels: Estyme Smooth and Estyme Form, currently marketed in the United States under the Evolysse brand, along with two new products, Estyme Lips and Estyme Sculpt. Estyme Sculpt is designed for restoring mid-face volume and is expecting U.S. FDA approval later this year.</p> <p>The products are developed using Symatese's Cold-X technology, which the company states helps preserve the natural structure of the hyaluronic http://www.streetinsider.com/Corporate+News/Evolus+launches+Estyme+hyaluronic+acid+gels+in+Europe/26465710.html Mon, 11 May 2026 08:30:22 -0400 A.04927026 A.23887963 A.50214897 EOLS O.01223041 O.09434798 O.29688837 O.37510556 http://www.streetinsider.com/Corporate+News/Evolus+launches+Estyme+dermal+filler+collection+in+Europe/26465711.html <p>Evolus Inc. (NASDAQ: EOLS) announced the commercial launch of its Estyme injectable hyaluronic acid gel collection in Europe, scheduled for May 16. The launch marks the company's entry into the international dermal filler market.</p> <p>The Estyme collection includes four injectable hyaluronic acid gels: Estyme Smooth and Estyme Form, currently marketed in the United States as Evolysse, plus two new products, Estyme Lips and Estyme Sculpt. Estyme Sculpt, designed for mid-face volume restoration, represents the flagship product and is expecting U.S. FDA approval later this year.</p> <p>The products utilize Cold-X technology developed by Symatese, which aims to preserve the natural structure of the http://www.streetinsider.com/Corporate+News/Evolus+launches+Estyme+dermal+filler+collection+in+Europe/26465711.html Mon, 11 May 2026 08:30:22 -0400 A.04927026 A.23887963 A.50214897 EOLS O.01223041 O.09434798 O.29688837 O.37510556 http://www.streetinsider.com/Corporate+News/Evolus+launches+Estyme+dermal+filler+collection+in+Europe/26465711.html <p>Evolus Inc. (NASDAQ: EOLS) announced the commercial launch of its Estyme injectable hyaluronic acid gel collection in Europe, scheduled for May 16. The launch marks the company's entry into the international dermal filler market.</p> <p>The Estyme collection includes four injectable hyaluronic acid gels: Estyme Smooth and Estyme Form, currently marketed in the United States as Evolysse, plus two new products, Estyme Lips and Estyme Sculpt. Estyme Sculpt, designed for mid-face volume restoration, represents the flagship product and is expecting U.S. FDA approval later this year.</p> <p>The products utilize Cold-X technology developed by Symatese, which aims to preserve the natural structure of the http://www.streetinsider.com/Corporate+News/Evolus+launches+Estyme+dermal+filler+collection+in+Europe/26465711.html Mon, 11 May 2026 08:30:22 -0400 A.04927026 A.23887963 A.50214897 EOLS O.01223041 O.09434798 O.29688837 O.37510556 http://www.streetinsider.com/Corporate+News/Evolus+launches+Estyme+dermal+filler+collection+in+Europe/26465711.html <p>Evolus Inc. (NASDAQ: EOLS) announced the commercial launch of its Estyme injectable hyaluronic acid gel collection in Europe, scheduled for May 16. The launch marks the company's entry into the international dermal filler market.</p> <p>The Estyme collection includes four injectable hyaluronic acid gels: Estyme Smooth and Estyme Form, currently marketed in the United States as Evolysse, plus two new products, Estyme Lips and Estyme Sculpt. Estyme Sculpt, designed for mid-face volume restoration, represents the flagship product and is expecting U.S. FDA approval later this year.</p> <p>The products utilize Cold-X technology developed by Symatese, which aims to preserve the natural structure of the http://www.streetinsider.com/Corporate+News/Evolus+launches+Estyme+dermal+filler+collection+in+Europe/26465711.html Mon, 11 May 2026 08:30:22 -0400 A.04927026 A.23887963 A.50214897 EOLS O.01223041 O.09434798 O.29688837 O.37510556 http://www.streetinsider.com/Corporate+News/Evolus+launches+Estyme+dermal+filler+collection+in+Europe/26465711.html <p>Evolus Inc. (NASDAQ: EOLS) announced the commercial launch of its Estyme injectable hyaluronic acid gel collection in Europe, scheduled for May 16. The launch marks the company's entry into the international dermal filler market.</p> <p>The Estyme collection includes four injectable hyaluronic acid gels: Estyme Smooth and Estyme Form, currently marketed in the United States as Evolysse, plus two new products, Estyme Lips and Estyme Sculpt. Estyme Sculpt, designed for mid-face volume restoration, represents the flagship product and is expecting U.S. FDA approval later this year.</p> <p>The products utilize Cold-X technology developed by Symatese, which aims to preserve the natural structure of the http://www.streetinsider.com/Corporate+News/Evolus+launches+Estyme+dermal+filler+collection+in+Europe/26465711.html Mon, 11 May 2026 08:30:22 -0400 A.04927026 A.23887963 A.50214897 EOLS O.01223041 O.09434798 O.29688837 O.37510556 http://www.streetinsider.com/Corporate+News/Evolus+launches+Estyme+dermal+filler+collection+in+Europe/26465711.html <p>Evolus Inc. (NASDAQ: EOLS) announced the commercial launch of its Estyme injectable hyaluronic acid gel collection in Europe, scheduled for May 16. The launch marks the company's entry into the international dermal filler market.</p> <p>The Estyme collection includes four injectable hyaluronic acid gels: Estyme Smooth and Estyme Form, currently marketed in the United States as Evolysse, plus two new products, Estyme Lips and Estyme Sculpt. Estyme Sculpt, designed for mid-face volume restoration, represents the flagship product and is expecting U.S. FDA approval later this year.</p> <p>The products utilize Cold-X technology developed by Symatese, which aims to preserve the natural structure of the http://www.streetinsider.com/Corporate+News/Evolus+launches+Estyme+dermal+filler+collection+in+Europe/26465711.html Mon, 11 May 2026 08:30:22 -0400 A.04927026 A.23887963 A.50214897 EOLS O.01223041 O.09434798 O.29688837 O.37510556 http://www.streetinsider.com/Corporate+News/Evolus+launches+Estyme+dermal+filler+collection+in+Europe/26465711.html <p>Evolus Inc. (NASDAQ: EOLS) announced the commercial launch of its Estyme injectable hyaluronic acid gel collection in Europe, scheduled for May 16. The launch marks the company's entry into the international dermal filler market.</p> <p>The Estyme collection includes four injectable hyaluronic acid gels: Estyme Smooth and Estyme Form, currently marketed in the United States as Evolysse, plus two new products, Estyme Lips and Estyme Sculpt. Estyme Sculpt, designed for mid-face volume restoration, represents the flagship product and is expecting U.S. FDA approval later this year.</p> <p>The products utilize Cold-X technology developed by Symatese, which aims to preserve the natural structure of the http://www.streetinsider.com/Corporate+News/Evolus+launches+Estyme+dermal+filler+collection+in+Europe/26465711.html Mon, 11 May 2026 08:30:22 -0400 A.04927026 A.23887963 A.50214897 EOLS O.01223041 O.09434798 O.29688837 O.37510556 http://www.streetinsider.com/Corporate+News/Evolus+launches+Estyme+dermal+filler+collection+in+Europe/26465711.html <p>Evolus Inc. (NASDAQ: EOLS) announced the commercial launch of its Estyme injectable hyaluronic acid gel collection in Europe, scheduled for May 16. The launch marks the company's entry into the international dermal filler market.</p> <p>The Estyme collection includes four injectable hyaluronic acid gels: Estyme Smooth and Estyme Form, currently marketed in the United States as Evolysse, plus two new products, Estyme Lips and Estyme Sculpt. Estyme Sculpt, designed for mid-face volume restoration, represents the flagship product and is expecting U.S. FDA approval later this year.</p> <p>The products utilize Cold-X technology developed by Symatese, which aims to preserve the natural structure of the http://www.streetinsider.com/Corporate+News/Evolus+launches+Estyme+dermal+filler+collection+in+Europe/26465711.html Mon, 11 May 2026 08:30:22 -0400 A.04927026 A.23887963 A.50214897 EOLS O.01223041 O.09434798 O.29688837 O.37510556 http://www.streetinsider.com/Corporate+News/Evolus+launches+Estyme+dermal+filler+collection+in+Europe/26465711.html <p>Evolus Inc. (NASDAQ: EOLS) announced the commercial launch of its Estyme injectable hyaluronic acid gel collection in Europe, scheduled for May 16. The launch marks the company's entry into the international dermal filler market.</p> <p>The Estyme collection includes four injectable hyaluronic acid gels: Estyme Smooth and Estyme Form, currently marketed in the United States as Evolysse, plus two new products, Estyme Lips and Estyme Sculpt. Estyme Sculpt, designed for mid-face volume restoration, represents the flagship product and is expecting U.S. FDA approval later this year.</p> <p>The products utilize Cold-X technology developed by Symatese, which aims to preserve the natural structure of the http://www.streetinsider.com/Corporate+News/Evolus+launches+Estyme+dermal+filler+collection+in+Europe/26465711.html Mon, 11 May 2026 08:30:22 -0400 A.04927026 A.23887963 A.50214897 EOLS O.01223041 O.09434798 O.29688837 O.37510556 http://www.streetinsider.com/Press+Releases/Evolus+Announces+Commercial+Launch+of+Estyme%C2%AE+Injectable+Hyaluronic+Acid+Gels+in+Europe/26465688.html <p> NEWPORT BEACH, Calif.--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.evolus.com%2Four-culture%2F&amp;esheet=54532423&amp;newsitemid=20260511215620&amp;lan=en-US&amp;anchor=Evolus%2C+Inc.&amp;index=1&amp;md5=7a73193e30fae9c41c619a6b89db0d29" shape="rect">Evolus, Inc.</a> (NASDAQ: EOLS), a global performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today announced that the commercial launch of Estyme® (pronounced “esteem”), its injectable hyaluronic acid (HA) gel collection in Europe, is scheduled for May 16th, marking the company’s entry into the international dermal filler market. </p><p> The Estyme® collection includes four injectable HA gels that will cover a wide range of applications. The collection includes Estyme® Smooth and Estyme® Form, which are currently marketed in the United States under the brand Evolysse®, http://www.streetinsider.com/Press+Releases/Evolus+Announces+Commercial+Launch+of+Estyme%C2%AE+Injectable+Hyaluronic+Acid+Gels+in+Europe/26465688.html Mon, 11 May 2026 08:30:00 -0400 A.04927026 A.23887963 A.50214897 EOLS O.01223041 O.09434798 O.29688837 O.37510556 http://www.streetinsider.com/Press+Releases/Evolus+Announces+Commercial+Launch+of+Estyme%C2%AE+Injectable+Hyaluronic+Acid+Gels+in+Europe/26465688.html <p> NEWPORT BEACH, Calif.--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.evolus.com%2Four-culture%2F&amp;esheet=54532423&amp;newsitemid=20260511215620&amp;lan=en-US&amp;anchor=Evolus%2C+Inc.&amp;index=1&amp;md5=7a73193e30fae9c41c619a6b89db0d29" shape="rect">Evolus, Inc.</a> (NASDAQ: EOLS), a global performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today announced that the commercial launch of Estyme® (pronounced “esteem”), its injectable hyaluronic acid (HA) gel collection in Europe, is scheduled for May 16th, marking the company’s entry into the international dermal filler market. </p><p> The Estyme® collection includes four injectable HA gels that will cover a wide range of applications. The collection includes Estyme® Smooth and Estyme® Form, which are currently marketed in the United States under the brand Evolysse®, http://www.streetinsider.com/Press+Releases/Evolus+Announces+Commercial+Launch+of+Estyme%C2%AE+Injectable+Hyaluronic+Acid+Gels+in+Europe/26465688.html Mon, 11 May 2026 08:30:00 -0400 A.04927026 A.23887963 A.50214897 EOLS O.01223041 O.09434798 O.29688837 O.37510556 http://www.streetinsider.com/Press+Releases/Evolus+Announces+Commercial+Launch+of+Estyme%C2%AE+Injectable+Hyaluronic+Acid+Gels+in+Europe/26465688.html <p> NEWPORT BEACH, Calif.--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.evolus.com%2Four-culture%2F&amp;esheet=54532423&amp;newsitemid=20260511215620&amp;lan=en-US&amp;anchor=Evolus%2C+Inc.&amp;index=1&amp;md5=7a73193e30fae9c41c619a6b89db0d29" shape="rect">Evolus, Inc.</a> (NASDAQ: EOLS), a global performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today announced that the commercial launch of Estyme® (pronounced “esteem”), its injectable hyaluronic acid (HA) gel collection in Europe, is scheduled for May 16th, marking the company’s entry into the international dermal filler market. </p><p> The Estyme® collection includes four injectable HA gels that will cover a wide range of applications. The collection includes Estyme® Smooth and Estyme® Form, which are currently marketed in the United States under the brand Evolysse®, http://www.streetinsider.com/Press+Releases/Evolus+Announces+Commercial+Launch+of+Estyme%C2%AE+Injectable+Hyaluronic+Acid+Gels+in+Europe/26465688.html Mon, 11 May 2026 08:30:00 -0400 A.04927026 A.23887963 A.50214897 EOLS O.01223041 O.09434798 O.29688837 O.37510556 http://www.streetinsider.com/Press+Releases/Evolus+Announces+Commercial+Launch+of+Estyme%C2%AE+Injectable+Hyaluronic+Acid+Gels+in+Europe/26465688.html <p> NEWPORT BEACH, Calif.--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.evolus.com%2Four-culture%2F&amp;esheet=54532423&amp;newsitemid=20260511215620&amp;lan=en-US&amp;anchor=Evolus%2C+Inc.&amp;index=1&amp;md5=7a73193e30fae9c41c619a6b89db0d29" shape="rect">Evolus, Inc.</a> (NASDAQ: EOLS), a global performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today announced that the commercial launch of Estyme® (pronounced “esteem”), its injectable hyaluronic acid (HA) gel collection in Europe, is scheduled for May 16th, marking the company’s entry into the international dermal filler market. </p><p> The Estyme® collection includes four injectable HA gels that will cover a wide range of applications. The collection includes Estyme® Smooth and Estyme® Form, which are currently marketed in the United States under the brand Evolysse®, http://www.streetinsider.com/Press+Releases/Evolus+Announces+Commercial+Launch+of+Estyme%C2%AE+Injectable+Hyaluronic+Acid+Gels+in+Europe/26465688.html Mon, 11 May 2026 08:30:00 -0400 A.04927026 A.23887963 A.50214897 EOLS O.01223041 O.09434798 O.29688837 O.37510556 http://www.streetinsider.com/Press+Releases/Evolus+Announces+Commercial+Launch+of+Estyme%C2%AE+Injectable+Hyaluronic+Acid+Gels+in+Europe/26465688.html <p> NEWPORT BEACH, Calif.--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.evolus.com%2Four-culture%2F&amp;esheet=54532423&amp;newsitemid=20260511215620&amp;lan=en-US&amp;anchor=Evolus%2C+Inc.&amp;index=1&amp;md5=7a73193e30fae9c41c619a6b89db0d29" shape="rect">Evolus, Inc.</a> (NASDAQ: EOLS), a global performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today announced that the commercial launch of Estyme® (pronounced “esteem”), its injectable hyaluronic acid (HA) gel collection in Europe, is scheduled for May 16th, marking the company’s entry into the international dermal filler market. </p><p> The Estyme® collection includes four injectable HA gels that will cover a wide range of applications. The collection includes Estyme® Smooth and Estyme® Form, which are currently marketed in the United States under the brand Evolysse®, http://www.streetinsider.com/Press+Releases/Evolus+Announces+Commercial+Launch+of+Estyme%C2%AE+Injectable+Hyaluronic+Acid+Gels+in+Europe/26465688.html Mon, 11 May 2026 08:30:00 -0400 A.04927026 A.23887963 A.50214897 EOLS O.01223041 O.09434798 O.29688837 O.37510556